It was reported that a patient experienced facial edema, conjunctivitis and dyspnea while performing therapy for the first time using a polyflux 140h.The incident occurred five minutes into treatment.Treatment was immediately terminated and the patient was treated with 200 mg of prednisolone, 1 amp of tavergil ("volume intravenous").The patient was hospitalized in the intensive care unit.At the time of this report, the patient outcome was reported as "stable".No additional information is available.
|